vs

Side-by-side financial comparison of KRONOS WORLDWIDE INC (KRO) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

KRONOS WORLDWIDE INC is the larger business by last-quarter revenue ($418.3M vs $309.9M, roughly 1.3× OMNICELL, INC.). OMNICELL, INC. runs the higher net margin — 3.7% vs -19.8%, a 23.5% gap on every dollar of revenue. On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs -1.1%). KRONOS WORLDWIDE INC produced more free cash flow last quarter ($81.9M vs $38.6M). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs -6.5%).

Kronos Incorporated was an American multinational workforce management and human capital management cloud provider headquartered in Lowell, Massachusetts, United States, which employed more than 6,000 people worldwide.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

KRO vs OMCL — Head-to-Head

Bigger by revenue
KRO
KRO
1.3× larger
KRO
$418.3M
$309.9M
OMCL
Growing faster (revenue YoY)
OMCL
OMCL
+16.0% gap
OMCL
14.9%
-1.1%
KRO
Higher net margin
OMCL
OMCL
23.5% more per $
OMCL
3.7%
-19.8%
KRO
More free cash flow
KRO
KRO
$43.3M more FCF
KRO
$81.9M
$38.6M
OMCL
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
-6.5%
KRO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KRO
KRO
OMCL
OMCL
Revenue
$418.3M
$309.9M
Net Profit
$-82.8M
$11.4M
Gross Margin
-0.9%
45.3%
Operating Margin
-15.1%
60.1%
Net Margin
-19.8%
3.7%
Revenue YoY
-1.1%
14.9%
Net Profit YoY
-527.3%
EPS (diluted)
$-0.72
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRO
KRO
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$418.3M
$314.0M
Q3 25
$456.9M
$310.6M
Q2 25
$494.4M
$290.6M
Q1 25
$489.8M
$269.7M
Q4 24
$423.1M
$306.9M
Q3 24
$484.7M
$282.4M
Q2 24
$500.5M
$276.8M
Net Profit
KRO
KRO
OMCL
OMCL
Q1 26
$11.4M
Q4 25
$-82.8M
Q3 25
$-37.0M
$5.5M
Q2 25
$-9.2M
$5.6M
Q1 25
$18.1M
$-7.0M
Q4 24
$-13.2M
Q3 24
$71.8M
$8.6M
Q2 24
$19.5M
$3.7M
Gross Margin
KRO
KRO
OMCL
OMCL
Q1 26
45.3%
Q4 25
-0.9%
41.5%
Q3 25
10.3%
43.3%
Q2 25
12.7%
43.9%
Q1 25
21.8%
41.1%
Q4 24
20.4%
46.2%
Q3 24
20.9%
43.3%
Q2 24
20.0%
41.3%
Operating Margin
KRO
KRO
OMCL
OMCL
Q1 26
60.1%
Q4 25
-15.1%
0.1%
Q3 25
-4.2%
2.7%
Q2 25
1.5%
2.8%
Q1 25
7.8%
-4.3%
Q4 24
6.8%
4.0%
Q3 24
8.0%
2.3%
Q2 24
7.2%
1.2%
Net Margin
KRO
KRO
OMCL
OMCL
Q1 26
3.7%
Q4 25
-19.8%
Q3 25
-8.1%
1.8%
Q2 25
-1.9%
1.9%
Q1 25
3.7%
-2.6%
Q4 24
-3.1%
Q3 24
14.8%
3.1%
Q2 24
3.9%
1.3%
EPS (diluted)
KRO
KRO
OMCL
OMCL
Q1 26
$0.25
Q4 25
$-0.72
$-0.05
Q3 25
$-0.32
$0.12
Q2 25
$-0.08
$0.12
Q1 25
$0.16
$-0.15
Q4 24
$-0.11
$0.34
Q3 24
$0.62
$0.19
Q2 24
$0.17
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRO
KRO
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$33.2M
$239.2M
Total DebtLower is stronger
$557.4M
Stockholders' EquityBook value
$751.1M
$1.3B
Total Assets
$1.8B
$2.0B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRO
KRO
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$33.2M
$196.5M
Q3 25
$27.7M
$180.1M
Q2 25
$18.9M
$399.0M
Q1 25
$20.5M
$386.8M
Q4 24
$106.7M
$369.2M
Q3 24
$94.8M
$570.6M
Q2 24
$133.8M
$556.8M
Total Debt
KRO
KRO
OMCL
OMCL
Q1 26
Q4 25
$557.4M
Q3 25
$626.2M
Q2 25
$589.3M
Q1 25
$557.2M
Q4 24
$507.4M
Q3 24
$554.3M
Q2 24
$423.7M
Stockholders' Equity
KRO
KRO
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$751.1M
$1.2B
Q3 25
$804.7M
$1.2B
Q2 25
$846.8M
$1.3B
Q1 25
$847.0M
$1.3B
Q4 24
$817.0M
$1.2B
Q3 24
$847.4M
$1.2B
Q2 24
$774.6M
$1.2B
Total Assets
KRO
KRO
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$1.8B
$2.0B
Q3 25
$1.9B
$1.9B
Q2 25
$1.9B
$2.1B
Q1 25
$1.9B
$2.2B
Q4 24
$1.9B
$2.1B
Q3 24
$1.9B
$2.3B
Q2 24
$1.7B
$2.3B
Debt / Equity
KRO
KRO
OMCL
OMCL
Q1 26
Q4 25
0.74×
Q3 25
0.78×
Q2 25
0.70×
Q1 25
0.66×
Q4 24
0.62×
Q3 24
0.65×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRO
KRO
OMCL
OMCL
Operating Cash FlowLast quarter
$92.1M
$54.5M
Free Cash FlowOCF − Capex
$81.9M
$38.6M
FCF MarginFCF / Revenue
19.6%
12.5%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$-40.4M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRO
KRO
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$92.1M
$30.4M
Q3 25
$-7.9M
$28.3M
Q2 25
$20.7M
$42.8M
Q1 25
$-102.4M
$25.9M
Q4 24
$49.3M
$56.3M
Q3 24
$28.3M
$22.8M
Q2 24
$38.2M
$58.7M
Free Cash Flow
KRO
KRO
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$81.9M
$22.6M
Q3 25
$-17.4M
$18.5M
Q2 25
$9.5M
$31.0M
Q1 25
$-114.4M
$14.8M
Q4 24
$37.0M
$47.2M
Q3 24
$19.2M
$13.9M
Q2 24
$34.8M
$49.1M
FCF Margin
KRO
KRO
OMCL
OMCL
Q1 26
12.5%
Q4 25
19.6%
7.2%
Q3 25
-3.8%
6.0%
Q2 25
1.9%
10.7%
Q1 25
-23.4%
5.5%
Q4 24
8.7%
15.4%
Q3 24
4.0%
4.9%
Q2 24
7.0%
17.8%
Capex Intensity
KRO
KRO
OMCL
OMCL
Q1 26
Q4 25
2.4%
2.5%
Q3 25
2.1%
3.1%
Q2 25
2.3%
4.1%
Q1 25
2.4%
4.1%
Q4 24
2.9%
3.0%
Q3 24
1.9%
3.1%
Q2 24
0.7%
3.5%
Cash Conversion
KRO
KRO
OMCL
OMCL
Q1 26
4.80×
Q4 25
Q3 25
5.18×
Q2 25
7.58×
Q1 25
-5.66×
Q4 24
Q3 24
0.39×
2.64×
Q2 24
1.96×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KRO
KRO

Segment breakdown not available.

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons